PAGEInsider
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | Feb 03 '26 | Sale | 498.09 | 1,500 | 747,135 | 30,003 | Feb 05 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | Sep 08 '25 | Sale | 418.84 | 3,836 | 1,606,670 | 31,503 | Sep 08 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | Sep 04 '25 | Option Exercise | 173.12 | 10,920 | 1,890,470 | 42,423 | Sep 08 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | Sep 12 '24 | Sale | 385.42 | 8,358 | 3,221,340 | 29,678 | Sep 12 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | Sep 10 '24 | Option Exercise | 145.24 | 22,080 | 3,206,899 | 51,758 | Sep 12 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | May 09 '24 | Sale | 316.88 | 6,311 | 1,999,825 | 29,624 | May 13 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | May 07 '24 | Option Exercise | 139.06 | 18,660 | 2,594,860 | 52,784 | May 08 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | May 06 '24 | Sale | 309.00 | 1,600 | 494,400 | 34,124 | May 08 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | Jan 31 '24 | Sale | 306.79 | 3,200 | 981,734 | 24,929 | Feb 02 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | Apr 28 '23 | Sale | 284.44 | 12,556 | 3,571,396 | 28,783 | May 02 |
| HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | Apr 24 '23 | Option Exercise | 101.16 | 32,020 | 3,239,143 | 60,803 | Apr 26 |